Editorial Commentary
Non-muscle invasive bladder cancer cystoscopic surveillance: from overuse to underuse and non-adherence impact
Abstract
The burden of non-muscle-invasive bladder cancer (NMIBC) surveillance is well known, including 8% surgical complication with up to 3% death, adding to anxiety, discomfort and health care expenditures (1-4).
